Coopervision INC.

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$14Mgeneral payments (2019-2025)
$873Kresearch payments (2019-2025)
29,880clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $1.8M
2020 $1.0M
2021 $1.3M
2022 $2.1M
2023 $2.5M
2024 $2.5M
2025 $2.6M

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Optometrist $13M
Corneal and Contact Management $525K
Ophthalmology $165K
Pediatrics (Optometrist) $99K
Vision Therapy $41K
Pediatrics $24K

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Roxanne Achong-Coan Ocoee, FL Corneal and Contact Management $158,572.02
Yue Liu Forest Grove, OR Optometrist $136,254.59
Frances Bynum Martin, TN Optometrist $136,128.82
Rajiv Patel Vancouver, WA Optometrist $114,269.78
Ethan Huisman Waukee, IA Optometrist $107,151.38
Doris Wong Pleasanton, CA Optometrist $96,826.61
Jashpal Rajasansi Gilbert, AZ Optometrist $95,470.19
Michael Shaheen Canton, OH Optometrist $89,359.34
Ashley Wallace-Tucker Houston, TX Optometrist $87,687.09
Ryan Smedley Westminster, CO Corneal and Contact Management $85,815.47

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.